MOTS-c and Tesamorelin Interaction

Synergistic
Mechanism-based 51% confidence

MOTS-c and Tesamorelin have a synergistic interaction with 51% confidence. MOTS-c helps counteract the insulin-disrupting effects of Tesamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects. These compounds primarily affect different organ systems.

Compound Profiles

MOTS-c

Mitochondrial-Derived Peptide | Metabolic Regulator

Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.

Half-life: ~30 minutes Typical dose: Start 5mg daily, increase to 10-15mg based on goals longevity, metabolic
ampknrf2 insulin disruptinginsulin sensitizingteratogenic
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Pancreas
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (MOTS-c, Tesamorelin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (MOTS-c, Tesamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take MOTS-c with Tesamorelin?

Yes, MOTS-c and Tesamorelin can generally be taken together. MOTS-c helps counteract the insulin-disrupting effects of Tesamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects.

Is MOTS-c and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between MOTS-c and Tesamorelin?

MOTS-c helps counteract the insulin-disrupting effects of Tesamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time MOTS-c and Tesamorelin?

MOTS-c has a half-life of ~30 minutes and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: MOTS-c vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.